Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
0.4220
Dollar change
+0.0377
Percentage change
9.81
%
Index- P/E- EPS (ttm)-1.63 Insider Own19.06% Shs Outstand45.90M Perf Week15.93%
Market Cap19.63M Forward P/E- EPS next Y-0.61 Insider Trans57.65% Shs Float36.18M Perf Month-3.08%
Income-58.35M PEG- EPS next Q-0.28 Inst Own25.96% Short Float1.23% Perf Quarter-25.55%
Sales1.78M P/S11.03 EPS this Y48.13% Inst Trans-35.73% Short Ratio0.89 Perf Half Y-74.27%
Book/sh0.35 P/B1.20 EPS next Y35.81% ROA-97.62% Short Interest0.44M Perf Year-80.37%
Cash/sh0.46 P/C0.91 EPS next 5Y- ROE-226.22% 52W Range0.30 - 2.61 Perf YTD-78.47%
Dividend Est.- P/FCF- EPS past 5Y-18.68% ROI-177.53% 52W High-83.83% Beta-0.12
Dividend TTM- Quick Ratio2.42 Sales past 5Y-43.84% Gross Margin-125.10% 52W Low42.57% ATR (14)0.05
Dividend Ex-Date- Current Ratio2.63 EPS Y/Y TTM15.47% Oper. Margin-3405.05% RSI (14)53.18 Volatility22.65% 11.19%
Employees107 Debt/Eq1.10 Sales Y/Y TTM2922.03% Profit Margin-3272.46% Recom1.40 Target Price3.75
Option/ShortYes / Yes LT Debt/Eq1.04 EPS Q/Q40.81% Payout- Rel Volume3.18 Prev Close0.38
Sales Surprise-14.41% EPS Surprise14.80% Sales Q/Q1057.63% EarningsAug 06 AMC Avg Volume499.60K Price0.42
SMA2010.13% SMA50-3.74% SMA200-63.73% Trades Volume1,586,426 Change9.81%
Date Action Analyst Rating Change Price Target Change
Jun-25-24Downgrade BTIG Research Buy → Neutral
Jul-28-23Initiated Piper Sandler Overweight $10
Jun-15-23Initiated BTIG Research Buy $15
Apr-28-21Initiated Truist Buy $12
Oct-22-19Initiated Oppenheimer Outperform $9
Oct-02-24 07:30AM
Sep-28-24 07:40AM
07:35AM
Sep-27-24 07:34AM
07:32AM
07:30AM Loading…
07:30AM
Sep-23-24 08:00AM
Aug-06-24 04:05PM
Jul-31-24 04:15PM
Jul-23-24 04:05PM
Jul-16-24 04:05PM
Jul-10-24 09:55AM
Jun-26-24 08:01AM
Jun-25-24 10:31AM
08:28AM
07:37AM Loading…
07:37AM
Jun-24-24 08:53PM
05:25PM
04:15PM
Jun-13-24 04:05PM
Jun-03-24 07:00AM
May-23-24 04:09PM
May-01-24 07:00AM
Mar-21-24 12:00PM
Mar-20-24 09:00AM
Feb-13-24 08:51AM
Feb-12-24 04:05PM
Jan-18-24 08:00AM
Dec-27-23 07:30AM
Dec-21-23 01:40AM
04:05PM Loading…
Nov-15-23 04:05PM
Nov-14-23 10:00AM
Nov-13-23 04:05PM
Nov-03-23 12:00PM
Oct-19-23 04:05PM
Oct-17-23 04:05PM
07:30AM
Oct-16-23 07:30AM
07:00AM
Oct-04-23 07:30AM
Oct-02-23 04:05PM
Sep-27-23 09:00AM
Sep-18-23 04:05PM
Sep-07-23 07:30AM
Sep-06-23 07:00AM
Aug-10-23 04:05PM
Aug-08-23 09:55AM
Aug-07-23 04:05PM
Aug-01-23 04:05PM
Jul-28-23 10:13AM
Jul-24-23 04:05PM
Jun-22-23 04:05PM
Jun-15-23 04:10PM
04:05PM
Jun-09-23 06:34AM
Jun-08-23 06:43AM
Jun-07-23 08:25AM
Jun-06-23 06:34AM
Jun-05-23 06:44AM
Jun-02-23 06:56AM
Jun-01-23 06:29AM
May-31-23 06:40AM
May-30-23 06:50AM
May-26-23 06:59AM
May-25-23 06:38AM
May-24-23 06:43AM
May-23-23 06:33AM
May-22-23 07:49AM
May-19-23 07:03AM
May-18-23 06:39AM
May-17-23 06:35AM
May-16-23 04:05PM
Apr-19-23 09:00AM
Mar-31-23 06:36AM
Mar-23-23 04:05PM
Mar-14-23 04:35PM
Mar-10-23 07:04AM
Feb-22-23 07:00AM
Feb-09-23 04:05PM
Jan-30-23 07:00AM
Jan-24-23 04:05PM
Jan-17-23 04:05PM
Dec-13-22 09:25AM
Nov-17-22 04:05PM
Nov-10-22 09:00AM
Nov-08-22 04:05PM
Oct-24-22 07:30AM
Oct-20-22 04:05PM
Oct-17-22 04:05PM
Oct-05-22 08:00AM
Oct-03-22 07:30AM
Sep-16-22 04:05PM
Aug-23-22 08:00AM
Aug-11-22 04:05PM
Jul-27-22 04:05PM
Jun-28-22 04:10PM
04:05PM
Jun-14-22 04:30PM
Jun-01-22 07:00AM
May-17-22 04:05PM
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carey RobertDirectorSep 26 '24Buy0.501,476,626744,6621,476,626Oct 01 09:58 PM
Lisi Steven A.CEO and Chairman of the BoardSep 26 '24Buy0.501,476,626744,6623,249,411Oct 01 09:27 PM
Avniel AmirOfficerAug 22 '24Proposed Sale0.46180,41583,442Aug 22 10:13 AM
Lisi Steven A.CEO and Chairman of the BoardAug 15 '24Buy0.3750,00018,3401,772,785Aug 19 06:06 AM
Lucera ErickDirectorAug 14 '24Buy0.4039,26615,56543,608Aug 15 05:09 PM
Carey RobertDirectorAug 14 '24Buy0.40100,00039,6803,076,864Aug 15 05:09 PM
Lisi Steven A.CEO and Chairman of the BoardAug 14 '24Buy0.39100,00038,6401,722,785Aug 15 05:09 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0513,73328,2170Dec 29 04:23 PM
Avniel AmirChief Business OfficerDec 28 '23Sale2.0611,26723,234685,760Dec 29 04:23 PM
Myers Jeff LynnChief Medical OfficerDec 27 '23Sale2.213,4237,57946,577Dec 29 04:15 PM
Lisi Steven A.CEO and Chairman of the BoardDec 18 '23Buy1.6377,775126,7971,536,471Dec 19 05:15 PM
Carey RobertDirectorDec 18 '23Buy1.641,200,0001,962,0002,374,454Dec 19 05:13 PM
Gaul Michael A.Chief Operating OfficerNov 16 '23Buy1.7710,00017,70088,150Nov 17 04:15 PM